TE_36605
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | LTR2B |
---|---|
TE superfamily | ERV1 |
TE class | LTR |
Gene | - |
Class | Intergenic |
Coding | Non-coding |
Tumor-specific score | 163.43 |
Counts of samples | TCGA_tumor:144; TCGA_normal:0; GTEx:0 |
TSS | chr21(+):24639243 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_36605.11 | - | Intergenic | Non-coding | Non-coding | chr21(+):24639244,24639447,24654080,24654264,24713916,24713936 |
teRNA_36605.12 | - | Intergenic | Non-coding | Non-coding | chr21(+):24639244,24639447,24654080,24654264,24732927,24732947 |
teRNA_36605.13 | - | Intergenic | Non-coding | Non-coding | chr21(+):24639244,24639447,24654080,24654264,24670096,24670116 |
teRNA_36605.14 | - | Intergenic | Non-coding | Non-coding | chr21(+):24639244,24639447,24654309,24654400,24658116,24658136 |
teRNA_36605.15 | - | Intergenic | Non-coding | Non-coding | chr21(+):24639244,24639447,24654309,24654400,24658127,24658147 |
teRNA_36605.16 | - | Intergenic | Non-coding | Non-coding | chr21(+):24639244,24639447,24654309,24654400,24713916,24713936 |
teRNA_36605.17 | - | Intergenic | Non-coding | Non-coding | chr21(+):24639244,24639447,24654309,24654400,24691833,24692006,24713916,24713936 |
teRNA_36605.18 | - | Intergenic | Non-coding | Non-coding | chr21(+):24639244,24639447,24654309,24654400,24657213,24657233 |
teRNA_36605.19 | - | Intergenic | Non-coding | Non-coding | chr21(+):24639244,24639447,24639671,24639691 |
teRNA_36605.20 | - | Intergenic | Non-coding | Non-coding | chr21(+):24639244,24639447,24732927,24733063,24734196,24734315,24734666,24734906,24764648,24764668 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.